<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37048133</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Systemic Lupus Erythematosus Patients with DNASE1L3&#xb7;Deficiency Have a Distinctive and Specific Genic Circular DNA Profile in Plasma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1061</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12071061</ELocationID><Abstract><AbstractText>Cell-free (cf) extrachromosomal circular DNA (eccDNA) has a potential clinical application as a biomarker. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a complex immunological pathogenesis, associated with autoantibody synthesis. A previous study found that SLE patients with deoxyribonuclease 1-like 3 (DNASE1L3) deficiency exhibit changes in the frequency of short and long eccDNA in plasma compared to controls. Here, using the DifCir method for differential analysis of short-read sequenced purified eccDNA data based on the split-read signal of the eccDNA on circulomics data, we show that SLE patients with DNASE1L3 deficiency have a distinctive profile of eccDNA excised by gene regions compared to controls. Moreover, this profile is specific; cf-eccDNA from the top 93 genes is detected in all SLE with DNASE1L3 deficiency samples, and none in the control plasma. The top protein coding gene producing eccDNA-carrying gene fragments is the transcription factor <i>BARX2,</i> which is involved in skeletal muscle morphogenesis and connective tissue development. The top gene ontology terms are 'positive regulation of torc1 signaling' and 'chondrocyte development'. The top Harmonizome terms are 'lymphopenia', 'metabolic syndrome x', 'asthma', 'cardiovascular system disease', 'leukemia', and 'immune system disease'. Here, we show that gene associations of cf-eccDNA can serve as a biomarker in the autoimmune rheumatic diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerovska</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0671-4277</Identifier><AffiliationInfo><Affiliation>Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, Calle Doctor Begiristain s/n, 20014 San Sebastian, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;zo-Bravo</LastName><ForeName>Marcos J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-3264-464X</Identifier><AffiliationInfo><Affiliation>Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, Calle Doctor Begiristain s/n, 20014 San Sebastian, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basque Foundation for Science, IKERBASQUE, Calle Mar&#xed;a D&#xed;az Harokoa 3, 48013 Bilbao, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Planck Institute for Molecular Biomedicine, Computational Biology and Bioinformatics, Roentgenstr. 20, 48149 Muenster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of Basque Country (UPV/EHU), 48940 Leioa, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004270">DNA, Circular</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C485421">DNASE1L3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004706">Endodeoxyribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491320">BARX2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004270" MajorTopicYN="N">DNA, Circular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004706" MajorTopicYN="N">Endodeoxyribonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNASE1L3</Keyword><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">circular DNA</Keyword><Keyword MajorTopicYN="N">differential</Keyword><Keyword MajorTopicYN="N">eccDNA</Keyword><Keyword MajorTopicYN="N">extrachromosomal</Keyword><Keyword MajorTopicYN="N">glomerulonephritis</Keyword><Keyword MajorTopicYN="N">rheumatic</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37048133</ArticleId><ArticleId IdType="pmc">PMC10093232</ArticleId><ArticleId IdType="doi">10.3390/cells12071061</ArticleId><ArticleId IdType="pii">cells12071061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mathapathi S., Chu C.Q. Contribution of Impaired DNASE1L3 Activity to Anti-DNA Autoantibody Production in Systemic Lupus Erythematosus. Rheumatol. Immunol. Res. 2022;3:17&#x2013;22. doi: 10.2478/rir-2022-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rir-2022-0003</ArticleId><ArticleId IdType="pmc">PMC9524810</ArticleId><ArticleId IdType="pubmed">36467024</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin S.T., Deng J., Ji L., Yukawa M., Chan R.W., Volpi S., Vaglio A., Fenaroli P., Bocca P., Cheng S.H., et al. Effects of nucleases on cell-free extrachromosomal circular DNA. JCI Insight. 2022;7:e156070. doi: 10.1172/jci.insight.156070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.156070</ArticleId><ArticleId IdType="pmc">PMC9089787</ArticleId><ArticleId IdType="pubmed">35451374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerovska D., Ara&#xfa;zo-Bravo M.J. Skeletal Muscles of Sedentary and Physically Active Aged People Have Distinctive Genic Extrachromosomal Circular DNA Profiles. Int. J. Mol. Sci. 2023;24:2736. doi: 10.3390/ijms24032736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032736</ArticleId><ArticleId IdType="pmc">PMC9917053</ArticleId><ArticleId IdType="pubmed">36769072</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger A.M., Lohse M., Usadel B. Trimmomatic: A flexible trimmer for Illumina Sequence Data. Bioinformatics. 2014;30:2114&#x2013;2120. doi: 10.1093/bioinformatics/btu170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Kiran S., Saha S., Su Z., Paulsen T., Chatrath A., Shibata Y., Shibata E., Dutta A. ATAC-seq identifies thousands of extrachromosomal circular DNA in cancer and cell lines. Sci. Adv. 2020;6:eaba2489. doi: 10.1126/sciadv.aba2489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba2489</ArticleId><ArticleId IdType="pmc">PMC7228742</ArticleId><ArticleId IdType="pubmed">32440553</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan A.R., Hall I.M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841&#x2013;842. doi: 10.1093/bioinformatics/btq033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq033</ArticleId><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Shtumpf M., Piroeva K.V., Agrawal S.P., Jacob D.R., Teif V.B. NucPosDB: A database of nucleosome positioning in vivo and nucleosomics of cell-free DNA. Chromosoma. 2022;131:19&#x2013;28. doi: 10.1007/s00412-021-00766-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-021-00766-9</ArticleId><ArticleId IdType="pmc">PMC8776978</ArticleId><ArticleId IdType="pubmed">35061087</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan R.W.Y., Serpas L., Ni M., Volpi S., Hiraki L.T., Tam L.S., Rashidfarrokhi A., Wong P.C.H., Tam L.H.P., Wang Y., et al. Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction. Am. J. Hum. Genet. 2020;107:882&#x2013;894. doi: 10.1016/j.ajhg.2020.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.09.006</ArticleId><ArticleId IdType="pmc">PMC7674998</ArticleId><ArticleId IdType="pubmed">33022220</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez D., Perl A. mTOR signaling: A central pathway to pathogenesis in systemic lupus erythematosus? Discov Med. 2010;9:173&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131182</ArticleId><ArticleId IdType="pubmed">20350481</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Zhang R., Shao M., Zhao X., Miao M., Chen J., Liu J., Zhang X., Zhang X., Jin Y., et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79:141&#x2013;149. doi: 10.1136/annrheumdis-2019-215396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215396</ArticleId><ArticleId IdType="pmc">PMC6937406</ArticleId><ArticleId IdType="pubmed">31537547</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Gerold K.D., Schober K., Probst L., Boerner K., Kim M.J., Ruckdeschel A., Serwold T., Kissler S. The Autoimmunity-Associated Gene CLEC16A Modulates Thymic Epithelial Cell Autophagy and Alters T Cell Selection. Immunity. 2015;42:942&#x2013;952. doi: 10.1016/j.immuni.2015.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.04.011</ArticleId><ArticleId IdType="pmc">PMC4439257</ArticleId><ArticleId IdType="pubmed">25979422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X.J., Klionsky D.J., Zhang H. Podocytes and autophagy: A potential therapeutic target in lupus nephritis. Autophagy. 2019;15:908&#x2013;912. doi: 10.1080/15548627.2019.1580512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1580512</ArticleId><ArticleId IdType="pmc">PMC6526813</ArticleId><ArticleId IdType="pubmed">30755075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam R.C., Lee A.L., Yang W., Lau C.S., Chan V.S. Systemic Lupus Erythematosus Patients Exhibit Reduced Expression of CLEC16A Isoforms in Peripheral Leukocytes. Int. J. Mol. Sci. 2015;16:4428. doi: 10.3390/ijms160714428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160714428</ArticleId><ArticleId IdType="pmc">PMC4519850</ArticleId><ArticleId IdType="pubmed">26121298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y. KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing. Nature. 2018;557:585&#x2013;589. doi: 10.1038/s41586-018-0128-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0128-9</ArticleId><ArticleId IdType="pubmed">29769719</ArticleId></ArticleIdList></Reference><Reference><Citation>David-Morrison G., Xu Z., Rui Y.N., Charng W.L., Jaiswal M., Yamamoto S., Xiong B., Zhang K., Sandoval H., Duraine L., et al. WAC Regulates mTOR Activity by Acting as an Adaptor for the TTT and Pontin/Reptin Complexes. Dev. Cell. 2016;36:139&#x2013;151. doi: 10.1016/j.devcel.2015.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2015.12.019</ArticleId><ArticleId IdType="pmc">PMC4730548</ArticleId><ArticleId IdType="pubmed">26812014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.S., Werth V.P. Identification of specific chondroitin sulfate species in cutaneous autoimmune disease. J. Histochem. Cytochem. 2011;59:780&#x2013;790. doi: 10.1369/0022155411411304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155411411304</ArticleId><ArticleId IdType="pmc">PMC3261606</ArticleId><ArticleId IdType="pubmed">21804080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroza L.S., Sauma M.F., Vasconcelos J.M., Takeshita L.Y., Ribeiro-Rodrigues E.M., Sastre D., Barbosa C.M., Chies J.A., Veit T.D., Lima C.P., et al. Systemic lupus erythematosus: Association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population. Lupus. 2011;20:265&#x2013;273. doi: 10.1177/0961203310385266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310385266</ArticleId><ArticleId IdType="pubmed">21233146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Monteagudo S., Lories R. EXT1 and EXT2 regulate chondrogenesis by modulation of WNT signaling. Osteoarthr. Cartil. 2018;26((Suppl. S1)):S97. doi: 10.1016/j.joca.2018.02.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2018.02.208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi S., Madden B.J., Debiec H., Charlesworth M.C., Gross L., Ravindran A., Hummel A.M., Specks U., Fervenza F.C., Ronco P. Exostosin 1/exostosin 2-associated membranous nephropathy. J. Am. Soc. Nephrol. 2019;30:1123&#x2013;1136. doi: 10.1681/ASN.2018080852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018080852</ArticleId><ArticleId IdType="pmc">PMC6551791</ArticleId><ArticleId IdType="pubmed">31061139</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Yang Z., Tao T., Yang M., Hu Z.X. Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report. Medicine. 2021;100:e24887. doi: 10.1097/MD.0000000000024887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024887</ArticleId><ArticleId IdType="pmc">PMC7939150</ArticleId><ArticleId IdType="pubmed">33655949</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller P.P., Caza T., Larsen C.P., Charu V. EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies. Nephrol. Dial. Transplant. 2023;38:396&#x2013;404. doi: 10.1093/ndt/gfac058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfac058</ArticleId><ArticleId IdType="pubmed">35278072</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E., Alvarez P., Merino R. TGF&#x3b2; Superfamily Members as Regulators of B Cell Development and Function-Implications for Autoimmunity. Int. J. Mol. Sci. 2018;19:3928. doi: 10.3390/ijms19123928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123928</ArticleId><ArticleId IdType="pmc">PMC6321615</ArticleId><ArticleId IdType="pubmed">30544541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Bang S.Y., Joo Y.B., Kim T., Lee H.S., Kang C., Bae S.C. Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus. J. Rheumatol. 2016;43:1045&#x2013;1049. doi: 10.3899/jrheum.150665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.150665</ArticleId><ArticleId IdType="pubmed">26980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedovic J., Ebert A., Tagoh H., Busslinger M. Pax5: A master regulator of B cell development and leukemogenesis. Adv. Immunol. 2011;111:179&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">21970955</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D.Y.H., Chan T.M. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments. Int. J. Mol. Sci. 2019;20:6231. doi: 10.3390/ijms20246231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks J., Saifudeen Z., Dipp S., El-Dahr S.S. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. J. Biol. Chem. 2003;278:34158&#x2013;34166. doi: 10.1074/jbc.M304543200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M304543200</ArticleId><ArticleId IdType="pubmed">12791684</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Dahr S.S., Saifudeen Z. Interactions between BdkrB2 and p53 genes in the developing kidney. Biol. Chem. 2013;394:347&#x2013;351. doi: 10.1515/hsz-2012-0281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2012-0281</ArticleId><ArticleId IdType="pubmed">23152407</ArticleId></ArticleIdList></Reference><Reference><Citation>Benslimane Y., S&#xe1;nchez-Osuna M., Coulombe-Huntington J., Bertomeu T., Henry D., Huard C., Bonneil &#xc9;., Thibault P., Tyers M., Harrington L. A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. Aging Cell. 2021;20:e13331. doi: 10.1111/acel.13331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13331</ArticleId><ArticleId IdType="pmc">PMC8045932</ArticleId><ArticleId IdType="pubmed">33660365</ArticleId></ArticleIdList></Reference><Reference><Citation>Puca R., Nardinocchi L., Sacchi A., Rechavi G., Givol D., D&#x2019;Orazi G. HIPK2 modulates p53 activity towards pro-apoptotic transcription. Mol. Cancer. 2009;8:85. doi: 10.1186/1476-4598-8-85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-8-85</ArticleId><ArticleId IdType="pmc">PMC2768676</ArticleId><ArticleId IdType="pubmed">19828042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Li S., Chen P., Yang B., Yang J., Liu R., Li J., Xia D. MicroRNA-27b-3p inhibits apoptosis of chondrocyte in rheumatoid arthritis by targeting HIPK2. Artif. Cells Nanomed. Biotechnol. 2019;47:1766&#x2013;1771. doi: 10.1080/21691401.2019.1607362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21691401.2019.1607362</ArticleId><ArticleId IdType="pubmed">31066587</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Tang H., Zhang Y., Tang X., Zhang J., Sun L., Yang J., Cui Y., Zhang L., Hirankarn N., et al. Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am. J. Hum. Genet. 2013;92:41&#x2013;51. doi: 10.1016/j.ajhg.2012.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.11.018</ArticleId><ArticleId IdType="pmc">PMC3542470</ArticleId><ArticleId IdType="pubmed">23273568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S., Ise W., Inoue T., Ito A., Ono C., Shima Y., Sakakibara S., Nakayama M., Fujii K., Miura I., et al. Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity. Nat. Immunol. 2020;21:950&#x2013;961. doi: 10.1038/s41590-020-0700-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0700-y</ArticleId><ArticleId IdType="pubmed">32572241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouillard A.D., Gundersen G.W., Fernandez N.F., Wang Z., Monteiro C.D., McDermott M.G., Ma&#x2019;ayan A. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. 2016;2016:baw100. doi: 10.1093/database/baw100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baw100</ArticleId><ArticleId IdType="pmc">PMC4930834</ArticleId><ArticleId IdType="pubmed">27374120</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M., Guffroy A., Argemi X., Martin T. Lupus &#xe9;ryth&#xe9;mateux syst&#xe9;mique et lymphop&#xe9;nie: Aspects cliniques et physiopathologiques [Systemic lupus erythematosus and lymphopenia: Clinical and pathophysiological features] Rev. Med. Interne. 2017;38:603&#x2013;613. doi: 10.1016/j.revmed.2017.01.005. (In French)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.revmed.2017.01.005</ArticleId><ArticleId IdType="pubmed">28214184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel S.M., Abdel Azeem Abd Elazeem M.E.M.I., Mohamed R.A., Kamel M.M., Abdel Aleem Abdelaleem E.A. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus. Int. J. Immunopathol. Pharmacol. 2023;37:03946320231154988. doi: 10.1177/03946320231154988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03946320231154988</ArticleId><ArticleId IdType="pmc">PMC9893074</ArticleId><ArticleId IdType="pubmed">36718110</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N., Ponvilawan B., Wongtrakul W., Ungprasert P. Patients with asthma have a higher risk of systemic lupus erythematosus: A systematic review and meta-analysis. Clin. Rheumatol. 2021;40:529&#x2013;536. doi: 10.1007/s10067-020-05279-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05279-x</ArticleId><ArticleId IdType="pubmed">32638252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller C.B., Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: The role of traditional and lupus related risk factors. Curr. Cardiol. Rev. 2008;4:116&#x2013;122. doi: 10.2174/157340308784245775.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157340308784245775</ArticleId><ArticleId IdType="pmc">PMC2779351</ArticleId><ArticleId IdType="pubmed">19936286</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosteg&#xe5;rd J. Systemic lupus erythematosus and cardiovascular disease. J. Intern. Med. 2023;293:48&#x2013;62. doi: 10.1111/joim.13557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13557</ArticleId><ArticleId IdType="pmc">PMC10087345</ArticleId><ArticleId IdType="pubmed">35982610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Wang Y., Wang Y., Bai Y., Gu D. Association between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings from Cohort Studies. Front. Oncol. 2022;12:860794. doi: 10.3389/fonc.2022.860794.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.860794</ArticleId><ArticleId IdType="pmc">PMC9115099</ArticleId><ArticleId IdType="pubmed">35600353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollis E., Mosaku A., Abid A., Buniello A., Cerezo M., Gil L., Groza T., G&#xfc;ne&#x15f; O., Hall P., Hayhurst J., et al. The NHGRI-EBI GWAS Catalog: Knowledgebase and deposition resource. Nucleic Acids Res. 2022;51:D977&#x2013;D985. doi: 10.1093/nar/gkac1010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1010</ArticleId><ArticleId IdType="pmc">PMC9825413</ArticleId><ArticleId IdType="pubmed">36350656</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo Y.B., Lim J., Tsao B.P., Nath S.K., Kim K., Bae S.C. Genetic variants in systemic lupus erythematosus susceptibility loci, XKR6 and GLT1D1 are associated with childhood-onset SLE in a Korean cohort. Sci. Rep. 2018;8:9962. doi: 10.1038/s41598-018-28128-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28128-z</ArticleId><ArticleId IdType="pmc">PMC6028392</ArticleId><ArticleId IdType="pubmed">29967481</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y., Zhai Z.F., Chen F.R., Chen W., Hao F. Autoimmune risk loci of IL12RB2, IKZF1, XKR6, TMEM39A and CSK in Chinese patients with systemic lupus erythematosus. Tissue Antigen. 2015;85:200&#x2013;203. doi: 10.1111/tan.12522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.12522</ArticleId><ArticleId IdType="pubmed">25720506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J.Y., Han X., Qu B., Shen N. 82 Decreased expression of ANKRD44 associates with the overactivation of type I IFN signaling pathway in SLE. Lupus Sci. Med. 2019;6:A1&#x2013;A227. doi: 10.1136/lupus-2019-lsm.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2019-lsm.82</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.Y., Yang T.M., Ou R.W., Wei Q.Q., Shang H.F. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med. 2021;19:27. doi: 10.1186/s12916-021-01903-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01903-y</ArticleId><ArticleId IdType="pmc">PMC7863260</ArticleId><ArticleId IdType="pubmed">33541344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethunaickan R., Berthier C.C., Zhang W., Eksi R., Li H.D., Guan Y., Kretzler M., Davidson A. Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB &#xd7; NZW) F1 and NZM2410 mice. Arthritis Rheumatol. 2014;66:2246&#x2013;2258. doi: 10.1002/art.38679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38679</ArticleId><ArticleId IdType="pmc">PMC4554534</ArticleId><ArticleId IdType="pubmed">24757019</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Liu Z., Zhang B., Jiang S., Wang Q., Du L., Xue H., Zhang Y., Jin M., Zhu X., et al. Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sj&#xf6;gren&#x2019;s syndrome. Rheumatology. 2020;59:2603&#x2013;2615. doi: 10.1093/rheumatology/keaa163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa163</ArticleId><ArticleId IdType="pubmed">32250392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugano Y., Lindenmeyer M.T., Auberger I., Ziegler U., Segerer S., Cohen C.D., Neuhauss S.C., Loffing J. The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier. Kidney Int. 2015;88:1047&#x2013;1056. doi: 10.1038/ki.2015.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.197</ArticleId><ArticleId IdType="pubmed">26154927</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>